All Issue

2021 Vol.2, Issue 3

Review article

September 2021. pp. 85-91
Abstract
Sorry, not available.
Click the PDF button.
References
1
Society DJ et al., Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause, Maturitas, 2014
2
Nappi RE et al., Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause, Climacteric, 2014 10.3109/13697137.2013.87169624423885
3
Blakeman PJ et al., Mapping oestrogen and progesterone receptors throughout the female lower urinary tract, Neurourol Urodyn, 1996
4
Samsioe G et al., Occurrence, nature and treatment of urinary incontinence in a 70 years old female population, Maturitas, 1985 10.1016/0378-5122(85)90057-X
5
Scheiter F et al., Estrogenic sensitivity of α-receptors in the urethra musculature, Urologia internationalis, 1976
6
Bernstein IT. The pelvic floor muscles: muscle thickness in healthy and urinary-incontinent women measured by perineal ultasonography with reference to the effect of pelvic floor training, Oestrogen receptor studies, Neurourol Urodyn, 1997 10.1002/(SICI)1520-6777(1997)16:4<237::AID-NAU2>3.0.CO;2-F
7
Kinn AC et al., Oestrogens and phenylpropanolamine in combination for stress incontinence, Urology, 1988 10.1016/0090-4295(88)90400-1
8
Versi E et al., Oestrogens and lower urinary tract function. In: Studd JWW and Whitehead MI (eds) The menopause, Oxford: Blackwell Scientific Publications, 1988
9
Hextall A et al., Hormonal influences on the human female lower urinary tract: a prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation, Neurourol Urodyn, 1999
10
Van Geelen JM. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile, Am J Obstet Gynaecol, 1981 10.1016/0002-9378(81)90599-8
11
Robinson D. The effect of hormones on the lower urinary tract, Menopause Int, 2013 10.1177/175404531351139824336244
12
Cody JD. Oestrogen therapy for urinary incontinence in post-menopausal women, Cochrane Database Syst Rev, 2012 10.1002/14651858.CD001405.pub323076892PMC7086391
13
Cardozo L et al., systematic review of the effects of estrogens for symptoms suggestive of overactive bladder, Acta Obstet Gynecol Scand, 2004 10.1111/j.0001-6349.2004.00581.x15453881
14
Nappi RE et al., Vaginal Health: Insights Views & Attitudes (VIVA): results from an international survey, Climacteric, 2012 10.3109/13697137.2011.64784022168244
15
Avis NE et al., Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation, Menopause, 2009 10.3410/f.1160484.620849
16
Perrotta C et al., Oestrogens for preventing recurrent urinary tract infection in postmenopausal women, Cochrane Database Syst Rev, 2008 10.1002/14651858.CD005131.pub218425910
17
The North American Menopause Society. Menopause practice: a clinician's guide. 4th ed, Mayfield Heights, OH: NAMS, 2007
18
The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society, Menopause, 2020
19
Rahn DD et al., Vaginal estrogen for genitourinary syndrome of menopause: a systematic review, Obstet Gynecol, 2014 10.1097/AOG.000000000000052625415166PMC4855283
20
Raz R et al., A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections, N Engl J Med, 1993 10.1056/NEJM1993090932911028350884
21
Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infection in postmenopausal women, Am J Obstet Gynecol, 1999 10.1097/00006254-199909000-00014
22
Lethaby A et al., Local oestrogen for vaginal atrophy in postmenopausal women, Cochrane Database Syst Rev, 2016 10.1002/14651858.CD001500.pub327577677PMC7076628
23
Constantine GD et al., Endometrial safety of low dose vaginal estrogens in menopausal women: a systematic evidence review, Menopause, 2019 10.1097/GME.000000000000131530889085PMC6636806
24
Crandall CJ et al., Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study, Menopause, 2018 10.1097/GME.000000000000095628816933PMC5734988
25
Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence, Lancet, 2019
26
Schiavi MC et al., Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome: outcome after 6 months of treatment with ospemifene, Gynecol Endocrinol, 2018 10.1080/09513590.2017.137064528853624
27
Wilkinson EM et al., Personal and clinical vaginal lubricants: impact on local vaginal microenvironment and implications for epithelial cell host response and barrier function, J Infect Dis, 2019 10.1093/infdis/jiz41231539059PMC6834067
28
Franco MM et al., Pelvic Floor Muscle Training Effect in Sexual Function in Postmenopausal Women: A Randomized Controlled Trial, J Sex Med, 2021 10.1016/j.jsxm.2021.05.00534187758
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 2
  • No :3
  • Pages :85-91